The view from 10,000 procedures: technical tips and wisdom from master pancreatic surgeons to avoid hemorrhage during pancreaticoduodenectomy

BMC Surgery

Thomas J. Howard²  Charles M. Vollmer³  Elijah Dixon¹  Chad G. Ball¹ 

[1]Department of Surgery, University of Calgary, Foothills Medical Centre, 1403-29 Street NW, Calgary T2N 2T9, Alberta, Canada

[2]Department of Surgery, Indiana University, Indianapolis, IN, USA

[3]Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA

关键词: Pancreas;    Hemorrhage;    Whipple;    Pancreaticoduodenectomy;   

Others  :  1234522
DOI  :  10.1186/s12893-015-0109-y

 received in 2015-08-18, accepted in 2015-11-10,  发布年份 2015

【 摘 要 】

Pancreaticoduodenectomy remains the exclusive technique for surgical resection of cancers located within both the pancreatic head and periampullary region. Amongst peri-procedural complications, hemorrhage is particularly problematic given that allogenic blood transfusions are known to increase the risk of infection, acute lung injury, cancer recurrence and overall 30-day morbidity and mortality rates. Because blood loss can be considered a modifiable factor that reflects surgical technique, rates of perioperative blood loss and transfusion have been advocated as robust quality indicators. We present a correspondence manuscript that outlines peri-procedural concepts detailing a successful pancreaticoduodenectomy with minimal hemorrhage. These tips were collated from master pancreatic surgeons throughout the globe who have performed over 10,000 cumulative pancreaticoduodenectomies. At risk scenarios for hemorrhage include dissections of the superior mesenteric – portal vein, gastroduodenal artery, and retroperitoneal soft tissue margin. General principles in limiting slow continuous hemorrhage that may accumulate into larger total case losses are also discussed. While many of the techniques and tips proposed by master pancreas surgeons are intuitive and straight forward, when taken as a collective they represent a significant contribution to improved outcomes associated with the pancreaticoduodenectomy over the past 100 years.

【 授权许可】

   
2015 Ball et al.

【 参考文献 】

• [1]Kaush W. Das carcinoma der papilla und seine radikale entfernung. Beitrage zur Klinishen Chirugie. 1912; 78:29-33.
• [2]Whipple AO. The rationale of radical surgery for cancer of the pancreas and ampullary region. Ann Surg. 1941; 114:612-5.
• [3]Ball CG, Howard TJ. Does the type of pancreaticojejunostomy after whipple alter the leak rate? Adv Surg. 2010; 44:131-48.
• [4]Grutzmann R, Ruckert F, Hippe-Davies N, Distler M, Saeger HD. Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high volume center. Surgery. 2012; 151:612-20.
• [5]Ahmad SA, Edwards MJ, Sutton JM, Grewal SS, Hanseman DJ, Maithel SK et al.. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg. 2012; 256:529-34.
• [6]Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al.. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997; 226:248-60.
• [7]Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993; 217:430-5.
• [8]Langer B. Role of volume outcome data in assuring quality in HPB surgery. HPB. 2007; 9:330-4.
• [9]Sosa JA, Bowman HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD et al.. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998; 228:429-38.
• [10]Howard JM. Pancreatico-duodenectomy: forty-one consecutive whipple resections without an operative mortality. Ann Surg. 1968; 168:629-40.
• [11]Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consectuive resections withouat an operative mortality. Ann Surg. 1990; 211:447-58.
• [12]Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I et al.. Hospital volume and surgical mortality in the United States. NEJM. 2002; 346:1128-37.
• [13]Birkmeyer JD, Finlayson SRG, Tosteson ANA, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery. 1999; 125:250-6.
• [14]Crile G. The advantage of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970; 130:1049-53.
• [15]Herter FP, Cooperman AM, Ahlborn TN, Antinori C. Surgical experience with pancreatic and periampullary cancer. Ann Surg. 1982; 195:274-81.
• [16]Poon RTP, Fan ST. Decreasing the pancreatic leak rate after pancreaticoduodenectomy. Adv Surg. 2008; 42:33-48.
• [17]Agarwal N, Murphy JG, Cayten CG, Stahl WM. Blood transfusion increases the risk of infection after trauma. Arch Surg. 1993; 128:171-7.
• [18]Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogenic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003; 54:908-14.
• [19]McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogenic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg. 2001; 85:171-8.
• [20]Busch OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer: evidence of a noncausal relationship. Ann Surg. 1994; 220:791-7.
• [21]Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogenic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol). 2006; 18:60-6.
• [22]Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery. 1989; 106:836-41.
• [23]Nielson HJ. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995; 82:582-7.
• [24]Dixon E, Datta I, Sutherland FR, Vauthey J. Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol. 2009; 99:508-12.
• [25]Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg. 2003; 138:314-24.
• [26]Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg. 1973; 107:206-10.
• [27]Galandiuk S, Polk HC, Jagelman DG, Fazio VW. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gyencol Obstet. 1989; 169:219-22.
• [28]Proctor LD, Davenport DL, Bernard AC, Zwischenberger JB. General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg. 2010; 210:60-5.
• [29]Ball CG, Pitt HA, Kilbane M, Dixon E, Sutherland FR, Lillemoe KD. Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB. 2010; 12:465-71.
• [30]Strasberg SM, Bhalla S, Sanchez LA, Linehan DC. Pattern of venous collateral development after splenic vein occlusion in an extended Whipple procedure: comparison with collateral vein pattern in cases of sinistral portal hypertension. J Gastrointest Surg. 2011; 15:2070-9.
• [31]Ball CG, Kirkpatrick AW, Smith M. Traumatic injury to the superior mesenteric vein: ligate, repair or shunt? Eur J Trauma and Emerg Surg. 2007; 3:550-2.